{{Rsnum
|rsid=8192870
|Gene=CYP7A1
|Chromosome=8
|position=58499507
|Orientation=minus
|GMAF=0.2447
|Gene_s=CYP7A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 10.6 | 42.5 | 46.9
| HCB | 5.1 | 32.8 | 62.0
| JPT | 2.7 | 31.9 | 65.5
| YRI | 1.4 | 12.9 | 85.7
| ASW | 0.0 | 12.3 | 87.7
| CHB | 5.1 | 32.8 | 62.0
| CHD | 1.8 | 38.5 | 59.6
| GIH | 12.9 | 47.5 | 39.6
| LWK | 1.8 | 31.8 | 66.4
| MEX | 1.7 | 37.9 | 60.3
| MKK | 0.0 | 16.0 | 84.0
| TSI | 13.7 | 51.0 | 35.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23354620
|Title=Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients
}}

{{PMID Auto
|PMID=22882727
|Title=CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}